• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿酸与心房颤动之间的关联:一项系统评价和荟萃分析。

Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis.

作者信息

Tamariz Leonardo, Hernandez Fernando, Bush Aaron, Palacio Ana, Hare Joshua M

机构信息

Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida; Veterans Affairs Medical Center, Miami, Florida.

Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida; Veterans Affairs Medical Center, Miami, Florida.

出版信息

Heart Rhythm. 2014 Jul;11(7):1102-8. doi: 10.1016/j.hrthm.2014.04.003. Epub 2014 Apr 5.

DOI:10.1016/j.hrthm.2014.04.003
PMID:24709288
Abstract

BACKGROUND

Atrial fibrillation (AF) is mediated by oxidative stress, neurohormonal activation, and inflammatory activation. Serum uric acid (SUA) is a surrogate marker of oxidative stress. Xanthine oxidase produces SUA and is upregulated by inflammation and neurohormones.

OBJECTIVE

To perform a meta-analysis to evaluate the evidence supporting an association between AF and SUA.

METHODS

We searched the MEDLINE database (1966 to 2013) supplemented by manual searches of bibliographies of key relevant articles. We selected all cross-sectional and cohort studies in which SUA was measured and AF was reported. In cross-sectional studies, we calculated the pooled standardized mean difference of SUA between those with AF and those without AF. In cohort studies, we calculated the pooled relative risk with the corresponding 95% confidence interval (CI) for incident AF by using the random effects method.

RESULTS

The search strategy yielded 40 studies, of which only 9 met our eligibility criteria. The 6 cross-sectional studies comprised 7930 evaluable patients with a median prevalence of heart failure of 4% (IQR 0%-100%). The standardized mean difference of SUA for those with AF was 0.42 (95% CI 0.27-0.58) compared with those without AF. The 3 cohort studies evaluated 138,306 individuals without AF. The relative risk of having AF for those with high SUA was 1.67 (95% CI 1.23-2.27) compared with those with normal SUA.

CONCLUSION

High SUA is associated with AF in both cross-sectional and cohort studies. It is unclear whether SUA represents a disease marker or a treatment target.

摘要

背景

房颤(AF)由氧化应激、神经激素激活和炎症激活介导。血清尿酸(SUA)是氧化应激的替代标志物。黄嘌呤氧化酶产生SUA,并受炎症和神经激素上调。

目的

进行一项荟萃分析,以评估支持AF与SUA之间关联的证据。

方法

我们检索了MEDLINE数据库(1966年至2013年),并辅以手动检索关键相关文章的参考文献。我们选择了所有测量了SUA并报告了AF的横断面研究和队列研究。在横断面研究中,我们计算了AF患者与非AF患者之间SUA的合并标准化平均差。在队列研究中,我们采用随机效应方法计算了发生AF的合并相对风险及相应的95%置信区间(CI)。

结果

检索策略产生了40项研究,其中只有9项符合我们的纳入标准。6项横断面研究包括7930例可评估患者,心力衰竭的中位患病率为4%(四分位间距0%-100%)。与非AF患者相比,AF患者的SUA标准化平均差为0.42(95%CI 0.27-0.58)。3项队列研究评估了138,306例无AF的个体。与SUA正常的个体相比,SUA高的个体发生AF的相对风险为1.67(95%CI 1.23-2.27)。

结论

在横断面研究和队列研究中,高SUA均与AF相关。尚不清楚SUA是代表疾病标志物还是治疗靶点。

相似文献

1
Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis.血清尿酸与心房颤动之间的关联:一项系统评价和荟萃分析。
Heart Rhythm. 2014 Jul;11(7):1102-8. doi: 10.1016/j.hrthm.2014.04.003. Epub 2014 Apr 5.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Systematic screening for the detection of atrial fibrillation.用于检测心房颤动的系统筛查。
Cochrane Database Syst Rev. 2016 Jun 3;2016(6):CD009586. doi: 10.1002/14651858.CD009586.pub3.
4
Exercise-based cardiac rehabilitation for adults with atrial fibrillation.针对患有心房颤动的成年人的基于运动的心脏康复。
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD011197. doi: 10.1002/14651858.CD011197.pub2.
5
Effectiveness of systematic screening for the detection of atrial fibrillation.系统性筛查用于检测心房颤动的有效性。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009586. doi: 10.1002/14651858.CD009586.pub2.
6
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation.在心房颤动患者中,Xa因子抑制剂与维生素K拮抗剂预防脑栓塞或全身性栓塞的比较
Cochrane Database Syst Rev. 2013 Aug 8(8):CD008980. doi: 10.1002/14651858.CD008980.pub2.
7
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
8
Exercise-based cardiac rehabilitation for adults with atrial fibrillation.基于运动的心房颤动成人心脏康复。
Cochrane Database Syst Rev. 2024 Sep 17;9(9):CD011197. doi: 10.1002/14651858.CD011197.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Association Between Serum Uric Acid and Atrial Fibrillation in Patients With Hypertension: A Systematic Review and Meta-Analysis.高血压患者血清尿酸与心房颤动之间的关联:一项系统评价与Meta分析
Rev Cardiovasc Med. 2025 May 27;26(5):28168. doi: 10.31083/RCM28168. eCollection 2025 May.
2
A machine learning-based model for predicting paroxysmal and persistent atrial fibrillation based on EHR.一种基于电子健康记录(EHR)的用于预测阵发性和持续性心房颤动的机器学习模型。
BMC Med Inform Decis Mak. 2025 Feb 3;25(1):51. doi: 10.1186/s12911-025-02880-5.
3
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment.
心房颤动中的代谢组学:揭示用于诊断、预后和个性化治疗的新型生物标志物和途径。
J Clin Med. 2024 Dec 25;14(1):34. doi: 10.3390/jcm14010034.
4
Cardiovascular Outcomes of Uric Acid Lowering Medications: A Meta-Analysis.降尿酸药物的心血管结局:一项荟萃分析。
Curr Cardiol Rep. 2024 Dec;26(12):1427-1437. doi: 10.1007/s11886-024-02138-y. Epub 2024 Oct 1.
5
Non-Traditional Risk Factors as Contributors to Cardiovascular Disease.作为心血管疾病成因的非传统风险因素
Rev Cardiovasc Med. 2023 Apr 28;24(5):134. doi: 10.31083/j.rcm2405134. eCollection 2023 May.
6
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives.心力衰竭治疗对心房颤动的影响:生物学和临床视角
Antioxidants (Basel). 2024 Jul 2;13(7):806. doi: 10.3390/antiox13070806.
7
Managing Gout in Patients with Metabolic Syndrome.代谢综合征患者的痛风管理。
Drugs Aging. 2024 Aug;41(8):653-663. doi: 10.1007/s40266-024-01132-x. Epub 2024 Jul 27.
8
A phenome-wide association and factorial Mendelian randomization study on the repurposing of uric acid-lowering drugs for cardiovascular outcomes.一项关于降低尿酸药物在心血管结局中的再利用的表型全基因组关联和因子 Mendelian 随机化研究。
Eur J Epidemiol. 2024 Aug;39(8):869-880. doi: 10.1007/s10654-024-01138-0. Epub 2024 Jul 11.
9
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.心房颤动中的代谢重塑:表现、机制及临床意义。
Nat Rev Cardiol. 2024 Oct;21(10):682-700. doi: 10.1038/s41569-024-01038-6. Epub 2024 May 30.
10
Gender differences in the relationship between serum uric acid and the long-term prognosis in heart failure: a nationwide study.血清尿酸与心力衰竭长期预后的关系存在性别差异:一项全国性研究。
Cardiovasc Diabetol. 2024 Apr 18;23(1):131. doi: 10.1186/s12933-024-02214-1.